tiprankstipranks
Trending News
More News >

Dimerix Limited Issues New Securities to Strengthen Market Position

Story Highlights
Dimerix Limited Issues New Securities to Strengthen Market Position

Confident Investing Starts Here:

Dimerix Limited ( (AU:DXB) ) has issued an announcement.

Dimerix Limited announced the issuance of 1,189,968 fully paid ordinary securities, which are set to be quoted on the Australian Securities Exchange (ASX) under the code DXB. This move, resulting from the exercise of options or conversion of other securities, is expected to enhance the company’s financial flexibility and potentially strengthen its market position.

The most recent analyst rating on (AU:DXB) stock is a Buy with a A$1.36 price target. To see the full list of analyst forecasts on Dimerix Limited stock, see the AU:DXB Stock Forecast page.

More about Dimerix Limited

Dimerix Limited operates in the biotechnology industry, focusing on the development of innovative therapies for unmet medical needs. The company primarily engages in research and development of pharmaceutical products, aiming to address significant health challenges.

Average Trading Volume: 3,244,024

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$354.4M

Find detailed analytics on DXB stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1